Research programme: psoriasis therapeutics - Sosei

Drug Profile

Research programme: psoriasis therapeutics - Sosei

Alternative Names: SD 208

Latest Information Update: 29 Mar 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sosei
  • Class
  • Mechanism of Action Cytokine modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • Available For Licensing Yes

Highest Development Phases

  • No development reported Psoriasis

Most Recent Events

  • 29 Mar 2011 No development reported - Preclinical for Psoriasis in Japan (PO)
  • 03 Mar 2008 Preclinical trials in Psoriasis in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top